NCT05147727

Drug-drug Interaction Study Between Fluconazole and Famitinib in Healthy Subjects

A Single-center, Open-label, Fixed-sequence Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics and Safety of Famitinib in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 22 (actual)
• Sponsor: Jiangsu HengRui Medicine Co., Ltd. · Industry
• Sex: All
• Age: 18 Years – 45 Years
• Healthy volunteers: Accepted

Summary

An open-label, fixed-sequence, drug-drug interaction study to evaluate the effects of fluconazole on the pharmacokinetics and safety of famitinib in healthy subjects.

Conditions

• Tumor

Interventions

Type	Name	Description
DRUG	Fluconazole、Famitinib	Fluconazole, once daily on Days 12 to 24; Famitinib, once daily on Days 1 and 15

Timeline

• Start date: 2022-03-14
• Primary completion: 2022-05-02
• Completion: 2022-05-02
• First posted: 2021-12-07
• Last updated: 2022-12-23

Locations

1 site across 1 country: China